This site is intended for Healthcare Professionals only.

Boehringer Ingelheim UK & Ireland appoints Vani Manja as Country Managing Director and Head of Human Pharma


Share post:

Boehringer Ingelheim UK & Ireland has appointed Vani Manja as its new Country Managing Director and Head of Human Pharma.

Manja has been associated with Boehringer Ingelheim for over 11 years, in successful leadership roles in Germany, the United States and most recently as General Manager, India.

Her career started as a commissioned officer in the Indian Army Ordnance Corps which preceded leadership roles at Becton Dickinson and McKinsey.

She brings extensive experience of strategy, marketing, sales, business development, people management, and cultural transformation and is passionate about tackling healthcare inequalities and advancing sustainable healthcare.

Commenting on her new role, Manja said: “It is with great heart that I bring the spirit of conscious leadership to my new role. I look forward to being fully present and partnering with key stakeholders in the healthcare ecosystem in our collective quest to improve health for humans and animals in the UK and Ireland.”

“Our customers, from healthcare professionals and patients, to veterinarians, farmers, pet and horse owners, count on us for continued delivery of innovation and for reliable access to our products and services. Our people are what make our business special, and my top priority is to ensure we maintain the values that Boehringer Ingelheim is known for throughout the world, including furthering conversations around equality, diversity, and inclusion.

Manja’s focus will also be to deliver on the company’s purpose of transforming lives for generations. She added: “Like many health systems around the world, the UK and Ireland are experiencing challenging times. I believe we must continue to do all we can to drive innovation in a way that better supports patients and brings more value to health care systems locally and nationally.”

Manja holds an MBA and MA in International Studies from the Wharton School at the University of Pennsylvania in Philadelphia, and a Bachelor’s degree with Honors in Chemistry from Delhi University.


Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...